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 NEUROLOGICAL DET??IORATION IN AMERICAN FOOTBALL PLAYERS 
CAITLIN M. LOSI 
ABSTRACT 
  Neurodegenerative diseases are believed to occur at an increased rate for those 
who participate in contact sports. More recent attention has been given to players of the 
National Football League after it was proposed that they are at an increased risk of 
developing neurodegenerative diseases including chronic traumatic encephalopathy 
(CTE), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS), and 
Alzheimer’s Disease (AD). 
         Though multiple studies have found a correlation between concussive and sub-
concussive events and the development of CTE, the validity of these is being questioned. 
Many of the brain specimens available to evaluate have been samples of convenience or 
were donated by concerned family members of those who were displaying signs of 
neurodegenerative diseases potentially biasing the results.  Additionally, recall bias is a 
concern in some studies due to athletes or family members of athletes giving histories of 
concussive or sub-concussive events many years after players had retired.  
         Current evidence regarding neurodegenerative diseases, including CTE, and their 
development in NFL players is not sufficient to make concrete conclusions. It has 
become clear that more information regarding CTE and its  progression needs to be 
gathered. The proposed study extends the analysis originally completed by Lehman et. al 
to determine if there is an increased risk of developing neurodegenerative diseases in 
NFL players who have played at least five seasons when compared to the general 
  vi 
population. Investigators will use the Life Table Analysis System (LTAS.NET) from the 
Center for Disease Control and Prevention (CDC) to analyze this cohort. It is impossible 
to investigate CTE as a cause of death directly; it has only recently been studied and will, 
therefore, not be found on death certificates as a listed cause of death. Thus, this study 
will use other neurodegenerative diseases (PD, ALS, AD) as a possible marker for CTE. 
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INTRODUCTION 
Background 
The definition of CTE was debated for many years and finally in 2015, the National 
Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of 
Biomedical Imaging and Bioengineering (NIBIB) worked with researchers to form a 
consensus on the neuropathological criteria for CTE. The group determined that the 
pathognomonic lesion of CTE is perivascular collections of hyperphosphorylated-tau 
protein (p-tau) within neurons, astrocytes, and cell processes around small vessels in an 
irregular pattern at the depths of the cortical sulci.1 The researchers also found that the p-
tau in CTE had an irregular spatial pattern that could be visualized at low magnification. 
The lesions found are distinct to CTE and are not found in other neurodegenerative 
tauopathy disorders. 
Chronic traumatic encephalopathy (CTE) was originally noted in boxers in the 
1920s by medical examiner Stanford Martland and was at the time referred to as the 
“punch drunk syndrome.”2 This term was used to define the neuropsychiatric condition 
found in boxers and, later, was more formally termed dementia pugilistica. 3 Over time it 
was observed that this neuropsychiatric syndrome affected both men and women who had 
a history of brain injury. In 1949 Critchley adopted the term chronic traumatic 
encephalopathy for the syndrome which is how it is referred to today.4 
 A clear need for more evaluation of CTE in the population of National Football 
League (NFL) players came in 1994 when the National Institute for Occupational Safety 
and Health (NIOSH) completed a mortality study of players. This revealed an increase in 
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nervous system deaths when compared to the United States population including four 
cases of Amyotrophic Lateral Sclerosis (ALS). The combination of the results of this 
study as well as the discovery that many retired NFL players were noted to have 
remaining unresolved neurologic sequelae, led to other studies to further evaluate the 
concerns regarding possible long-term consequences of multiple traumatic brain injuries 
(TBI).5 
Statement of the Problem 
In 2012, Lehman et al. looked into the overall mortality of NFL players who had passed 
away from the year 1960 up until 2007. This study was specifically looking into 
neurodegenerative causes of death, including Parkinson Disease (PD), Amyotrophic 
Lateral Sclerosis (ALS), and Alzheimer Disease (AD), as a proxy of CTE. They did not 
use CTE as a cause of death directly and it would be difficult to do so as it is not an 
International Classification of Diseases (ICD) listed cause of death. Also, not every NFL 
player’s brain has been examined for neuropathology; some players may have, thus, had 
underlying CTE neuropathology that was mistaken for another neurodegenerative disease 
or was missed due to lack of proper post-mortem examination.5 For example, studies 
completed by Gavett et. al and Stern et. al showed that when a person’s listed cause of 
death was PD, ALS, or AD it may have actually been due to CTE that was not properly 
diagnosed.6,7 For these reasons, Lehman and his team used other neurodegenerative 
causes of death to calculate a rough estimate of the incidence of CTE. They found that, 
though overall mortality was decreased when compared to men of the United States 
population, neurodegenerative mortality was increased. Some weaknesses of this study 
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that are important to note include the fact that there were only two deaths from AD which 
led to a lack of statistical significance until contributor causes were used. Also, 
investigators included three players who had ALS. These players should have been 
considered outliers and should not have been added to the cohort. Finally, this study used 
95% confidence intervals (CI) that included the value 1. 
 Though it had some weaknesses, this study outlines the importance of further 
investigation into CTE in NFL players. The focus of this literature review will be to 
analyze the available data on CTE. Also, a future study will be proposed to investigate 
what Lehman and his team had first revealed by suggesting an extension of the original 
study to include data of NFL players who have passed away from 2007 until 2017.  
Hypothesis 
 There is increased mortality from neurodegenerative causes in NFL players who have 
passed away from 2007 until 2017 compared to the general United States population.  
Objectives and specific aims 
There is a need for more information regarding neurological changes that occur when a 
person experiences multiple episodes of TBI. This is especially true regarding players in 
the NFL who may experience much higher levels of TBI due to the nature of their 
profession. To further analyze neurodegenerative causes of death among professional 
football players it is necessary extend the analysis of Lehman et. al to include players 
who have passed away in the years 2007 through 2017. 
• To extend the analysis of the data from the 2012 Lehman et. al study 
• To better describe the incidence of neurodegenerative mortality in NFL players 
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• To compare the incidence of neurodegenerative mortality in NFL players to the 
general United States population 
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REVIEW OF THE LITERATURE 
Overview of Chronic Traumatic Encephalopathy 
Definition 
In 2015 a consensus on the neuropathological criteria for chronic traumatic 
encephalopathy was completed by researchers and the National Institute of 
Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical 
Imaging and Bioengineering (NIBIB). It was determined that CTE has a pathognomonic 
lesion consisting of hyperphosphorylated-tau protein aggregates (p-tau) within neurons, 
astrocytes, and cell processes. These groupings tend to be perivascular and at the depths 
of the cortical sulci and there are extensive beta-amyloid (Aß) deposits. Also, the 
irregular spatial pattern of p-tau can be visualized at low magnification.1 It is important to 
note that the lesions described above are distinct to CTE and are not found in other 
neurodegenerative disorders. Researchers believe that CTE is acquired from multiple 
concussive or subconcussive events that may result from head trauma and has been noted 
in the brains of boxers as well as those who play contact sports. 2,8,9 
History 
Chronic Traumatic Encephalopathy has been noted since the 1920s, though under a 
different name, but almost one-hundred years later there is still much to be learned 
regarding the condition. In 1928 Martland described the “punch drunk” syndrome of 
boxers. He noted that this syndrome was common among fighters who received 
considerable amounts of head trauma, such as those who were used for training purposes 
and those who were less-skilled. The first sign of being punch drunk tended to be 
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unsteadiness of gait, though this did not affect a fighter’s performance. Some of these 
fighters may have also had confusion and an associated slowing of their movements in 
the ring, which led to referees believing them to be intoxicated. Increased motor issues 
including tremors and gait instability as well as mental deterioration were the final 
progression of this syndrome. Many times, this led to athletes being committed to 
asylums.2 
         Martland was the first to propose that this brain injury was due to concussion 
hemorrhages occurring in the deep portions of the cerebrum as a result of the head trauma 
experienced by boxers.2 He believed that these hemorrhages were then followed by 
gliosis, a degenerative progressive lesion in the affected area.2 In 1937 Millspaugh 
introduced the term “dementia pugilistica” (DP).10 Further investigations into dementia 
pugilistica took place throughout the 1960s. In an editorial in the Journal of the American 
Medical Association (JAMA) titled “(Ex?) Dementia Pugilistica in Ex-Boxers,” the 
question was posed as to whether this syndrome was an “independent entity” or whether 
it was a manifestation of chronic alcoholism that affected many boxers.3 Johnson was 
able to show that DP was not a result of alcoholism; it was a unique encephalopathy that 
did not occur in alcoholics who were not boxers.9 The incidence of DP was unable to be 
defined at the time. 
         In 1973 Corsellis et al. studied fifteen men who were former boxers to determine 
the neuropathology of what was then known as DP. They explained that DP is a condition 
that deals with damage to cerebellar, pyramidal, and extrapyramidal systems leading to 
dementia and social instability. These symptoms developed over time, either occurring 
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during a boxer’s career or many years after retirement. While studying the brains of these 
men researchers were able to find the presence of neurofibrillary tangles (NFT) without 
the presence of senile plaques distinguishing DP from Alzheimer’s Disease (AD). They 
were also able to detect other unique pathological findings: scarring of the cerebellum 
which may lead to ataxia; irregularities of the septum pellucidum, described as 
fenestration or cavum septum pellucidum, which may lead to decreased mental status, 
unstable gait, or psychosis; ventricular enlargement; thinning of the corpus callosum; 
neuronal loss of the locus coeruleus; and a lack of pigmented neurons within the 
substantia nigra. These unique pathological findings of DP would later also be added to 
the neuropathological findings of CTE. They determined that the damage they visualized 
was likely due to the trauma of linear and rotational acceleration of the head as a result 
the multiple hits to the head received while in the ring.11 
         A few years prior Critchley had coined Chronic Progressive Traumatic 
Encephalopathy, referred to as CTE today, as a term to replace DP as he believed it better 
described the neuropathology. CTE consists of chronic intellectual and neuropsychiatric 
symptoms after either a single or multiple occurrences of traumatic brain injury (TBI). 
Critchley described the clinical symptoms of CTE as slowness of thought and speech, 
emotional lability, memory problems, tremor, and dysarthria and proposed that they 
typically present within years to decades after a trauma. He concluded that more attention 
should be given to CTE especially when it came to the neuropathology of those with the 
syndrome.4 Two studies re-examined the brains of the male boxers originally studied by 
Corsellis and his team, which determined that the majority of these samples had extensive 
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beta-amyloid (Aß) deposits.12,13 Prior to these findings CTE (or DP as it was known at the 
time) was known for NFTs and no plaques but these studies importantly proved that CTE 
neuropathology also contains Aß plaque deposition. 
         As time progressed, it became clear that CTE was not a syndrome exclusive to 
male boxers. Data began to show that this condition could be found within both men and 
women and could occur as a result of direct head trauma of any sort. This included 
incidences of abuse, epilepsy, head-banging, and other contact sports. 
         Intimate-partner violence (IPV), or physical abuse between those in intimate 
relationships, often leads to longstanding issues as a result of physical bodily damage and 
psychological abuse. The majority of victims of IPV are women. Among those who seek 
medical treatment, the majority of injuries involve the head and are classified as 
concussions. Although there have been no studies directly investigating the relationship 
between IPV and TBI, there has been some evidence found in studies detailing the 
injuries of women exposed to IPV of increased rates of potential TBI in these victims. In 
a study done exploring the injuries of women exposed to IPV, it was found that 46% of 
the women surveyed stated that they had been repeatedly hit on the head and that, in 
some cases, this resulted in a loss of consciousness.14 The study by Roberts et al. 
describes one case of a 76-year old woman who had suffered from IPV. According to the 
patient’s family she had been the victim of violence from her husband for many years. 
Prior to her admission she had suffered a stroke and had been experiencing symptoms of 
dementia over the prior few years. On autopsy researchers determined that the 
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appearance of her brain resembled that of someone suffering from DP and that the most 
likely cause of her neurodegenerative process was IPV.15 
         Another condition that has been proposed to lead to CTE is epilepsy. Those who 
have temporal lobe epilepsy (TLE) are more likely to experience cognitive impairment. 
There are two different forms of cognitive impairment that are associated with TLE, a 
gradual decrease in cognition secondary to epilepsy and a step-wise decrease in cognition 
secondary to age or a discrete neurologic event, such as TBI. The study done by Tai et al. 
looked into discovering the pathological means to both of these known forms. They were 
able to examine tissue from thirty-three patients who had a temporal lobe resection to 
treat their drug-refractory TLE. The results of the study showed a possible overlap in the 
tauopathy of TLE with both AD and CTE; investigators found that their cohort had a 
mixture of tau pathology that was consistent with both AD and CTE with features of both 
neuropathologies present.16 These interesting results show that more studies need to be 
performed to better understand similarities within the pathology. 
         In a case report detailing neuropathology in a 24-year-old autistic woman with 
self-injurious behavior (SIB), Hof et al. were able to find some similarities with this 
woman’s brain specimen and those with known DP. Examination revealed NFTs in the 
neocortex that were perivascular and at the sulcal depth, which is consistent with the 
pathology of CTE. Though this pattern was similar, the authors noted that fewer lesions 
were found than would be expected in CTE. They also believe that their findings support 
the hypothesis that SIB can lead to long-term mental deterioration as a result of 
disruption within the brain that can cause brain lesions.17 An individual within the cohort 
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of the study by McKee et. al had a history of SIB in the form of head-banging and 
developed CTE. This allowed the investigators to conclude, along with two other cases in 
the literature of SIB leading to CTE, that a repetitive form of TBI such as SIB can be 
adequate to produce CTE in some individuals.18 
 In addition to boxing, other forms of contact sports have been shown to lead to 
CTE neuropathology. The first case of CTE within American football players was first 
described by Omalu et. al. in 2002.19 In 2010, Omalu and his team completed a case 
series of four NFL players and one case of a professional wrestler who died by suicide or 
parasuicide. The team was looking for immunohistochemical evidence of CTE within the 
brains of these athletes at autopsy. For this study, suicide was defined as “death arising 
from an act inflicted upon oneself with the intent to kill oneself” and parasuicide was 
defined as “all nonfatal suicidal behaviors regardless of their intentional nature.” 
 The case series involved five men with ages ranging from 36 to 50 years of age. 
Within the four football players the range of playing years in the NFL was from eight to 
seventeen years. Causes of death included myocardial infarction and suicide. Each 
individual in this series had developed signs of cognitive and neuropsychiatric decline 
and either exhibited suicidal or parasuicidal behavior prior to death or died by suicide. 
The researchers completed full neuropathologic inspections of each brain and found 
similar neuropathology that was consistent with CTE, 
         None of these men had a diagnosis of CTE prior to their deaths, though a method 
for pre-mortem diagnosis of CTE has yet to be developed. Researchers also explained the 
importance of neuropathologic examination of brains of individuals who take part in 
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contact sports. Their study shows that important information can be missed when making 
the determination of whether or not to perform immunohistochemical tissue analysis 
based on gross examination, as none of the five cases discussed above had any evidence 
of changes on gross visual exam except for trauma related to cause of death.20 
Neuropathology 
New advancements in the neuropathological study of CTE were noted when it was 
observed that following a single moderate or severe TBI that p-tau could be visualized 
along with Aß plaques. This study by McKee et. al obtained post-mortem brains from 
eighty-five subjects with known histories of TBI. In 80% of these specimens there were 
signs of chronic traumatic encephalopathy on examination. The signs of CTE included 
the distinct p-tau pathology that occurs perivascularly and at the sulcal depths.18 
  A control group consisted of eighteen specimens with no history of TBI that were 
age and gender-matched to the main cohort. Seven of the eighteen specimens of the 
control group had no p-tau pathology while the other eleven had Alzheimer’s-type 
neurofibrillary pathology. Within the cohort of those who experienced repetitive TBI 
researchers were able to find what was described as a spectrum of hyperphosphorylated 
tau pathology. P-tau was found to range in severity from small perivascular epicentres of 
NFTs to severe tauopathy that was widespread throughout different brain regions such as 
the medial temporal lobe. This allowed for staging of the neuropathology from least 
severe (stage I) to most severe (stage IV) that is detailed in Table 1. Within all four stages 
of CTE axonal loss within the deep cortex as well as subcortical white matter and axonal 
varicosities could be seen. In 85% of the cases there were TAR DNA-binding protein 43 
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inclusions and neurites. These were determined to be more centrally located in stages I to 
III and more extensive in stage IV. Researchers noted that the early stages of p-tau 
pathology in CTE are different than the observed AD-like pathology in young adults with 
no neurocognitive delays. They also found that these changes are a result of 
environmental exposure. Researchers found validity in their staging system due to the 
fact that as stages of CTE advanced there was noted to be a decrease in brain weight as 
well as an increase in the extent neurocognitive decline. 
Table 1: Distribution of Pathology in CTE According to McKee et. al 
Mild Pathology CTE Stage I: 
Perivascular p-tau NFTs in focal epicentres at the depths of the sulci 
in the superior, superior lateral or inferior frontal cortex; associated 
with headache and loss of attention and concentration 
  
CTE Stage II: 
NFTs in superficial cortical layers adjacent to the focal epicentres and 
in the nucleus basalis of Meynert and locus coeruleus; associated with 
depression and mood swings, explosivity, loss of attention and 
concentration, headache, and short-term memory loss 
Advanced 
Pathology 
CTE Stages III: 
Macroscopic evidence of mild cerebral atrophy, septal abnormalities, 
ventricular dilation, a sharply concave contour of the third ventricle, 
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and pigmentation of the locus coeruleus and substantia nigra. Dense 
p-tau pathology in medial temporal lobe structures (hippocampus, 
entorhinal cortex, and amygdala) and widespread regions of the 
frontal, septal, temporal, parietal, and insular cortices, diencephalon, 
brainstem, and spinal cord; associated with cognitive impairment with 
memory loss, executive dysfunction, loss of attention and 
concentration, depression, visuospatial abnormalities, and explosivity 
  
CTE Stage IV: 
Further cerebral, medial temporal lobe, hypothalamic, thalamic, and 
mammillary body atrophy, septal abnormalities, ventricular dilation, 
and pallor of the substantia nigra and locus coeruleus.  
Microscopically, p-tau pathology involved in widespread regions of 
the neuraxis including white matter, with prominent neuronal loss and 
gliosis of the cerebral cortex and hippocampal sclerosis; associated 
with profound short-term memory loss, executive dysfunction, 
attention and concetration loss, aggression, and explosivity. Most also 
showed paranoia, impulsivity, depression, and visuospatial 
abnormalities. 
Adapted from McKee et. al 2013 
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  An article by Gaetz points out differences in opinion when it comes to defining 
pathophysiology as well as symptomology of CTE.21  Two major studies detailed above 
examined the pathophysiology of CTE. Omalu et. al and McKee et. al had different 
criteria for the classification of CTE.18,20 The McKee group divided CTE into four stages 
based on severity of pathology while the Omalu group divided it into four 
histomorphologic phenotypes. These differences led to criticism and a call for a 
consensus on the definition of the neuropathological criteria for CTE, as described above 
(NINDS/NIBIB).1,22  
Symptomology 
Along with staging the neuropathological findings of CTE, researchers were also able to 
place symptoms into the different stages based on findings within the medical record and 
family interviews. In stage I of CTE, patients tend to experience the inability to 
concentrate, loss of attention, and headache. Stage II of CTE includes signs of 
depression, short-term memory loss, and explosivity. In stage III it was determined that 
patients suffer from cognitive impairment and executive dysfunction. Finally, stage IV 
includes dementia, aggression, and word-finding difficulty.18 
 Though McKee and her team were able to create their four stages of symptoms 
according to their research, prior to this there had been differences in opinion on CTE 
sympotomology classification. In his article Gaetz points out that early on simple 
characterizations were used to describe the manifestations of CTE such as memory issues 
and Parkinsonian symptoms. As time went on and more studies were completed, there 
was an added neuropsychiatric component. More recently there has been the development 
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of four categories of CTE symptomology: cognition, behavior, motor, and mood. 
Researchers have proposed that there are two clinical groups and that these groups 
present with different parts of the categories of CTE symptomology. There was 
determined to be a behavior/mood group, which had the qualities of explosivity, physical 
and verbal violence, and depression. The other group is the cognition group who tended 
to be older and to exhibit issues with memory and progression towards dementia.21,23 
Existing Research 
The study by McKee et. al was one of the first to evaluate a large number people with 
recurrent TBI to better calculate the risk of developing CTE. Researchers also 
specifically looked into American football players within their cohort and performed an 
analysis on the position they played to see if different positions led to an increased risk of 
developing CTE. Of the eighty-five donors within the experiment, fifty-eight played 
American football.18 Researchers excluded twenty-three of these players as they were 
known to have comorbid disease such as Alzheimer’s Disease (AD) or Parkinson’s 
Disease (PD) prior to the analysis or there was incomplete knowledge of their entire 
athletic careers. The thirty-five remaining players were then grouped by the primary 
position they held on the field. Of the thirty-five examined only one had no evidence of 
neurodegenerative disease. Of the thirty-five players examined, 89% were found to have 
stage III-IV CTE or CTE with a co-morbid disease that was found during examination. 
94% of the players had symptoms of CTE prior to their deaths, most commonly problems 
with short-term memory, loss of concentration, and loss of executive dysfunction with 
mean age of onset occurring at fifty-four (54.1 +/- 14.1 years). The mean age at death of 
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former players was sixty-seven (67.1 +/- 16.6 years) and the mean number of years spent 
playing football for this group was eleven years (11.9 +/- 6.5 years). When determining 
what factors may be significant between players and the development of CTE, 
researchers were able to find that the number of years played, the age at death, and the 
years since retirement were all significantly associated with the above-mentioned stages 
of CTE. The number of concussions suffered by the player (reported by family 
members), position on the field, years of education, and steroid use, however, were not 
significantly associated with progression of CTE.18 
         Though McKee et. al argue that there is a clear link between the development of 
CTE neuropathology and clinical symptomology of CTE, there remains some 
disagreement. Many investigators believe that the neuropathological changes in the 
brains of those who have experienced neurotrauma lead to changes in behavior and 
cognition. Alternatively, it has been hypothesized that this neurotrauma may instead put a 
person at a higher risk for age-related changes in behavior and cognition that are not a 
distinct process but are actually part of known disease courses. In this way, a person may 
have an accelerated decrease in what is known as cerebral reserve or cognitive reserve 
making him or her susceptible to late-life neurodegenerative conditions at an earlier 
age.22 In 2017 Gaetz proposed that four elements including neurotrauma, chronic pain, 
career transition stress, and substance abuse make up the Athlete Post-Career Adjustment 
(AP-CA) Model.21 Gaetz believes that together these elements can contribute to the 
symptoms experienced by NFL players in the period between retirement from the sport 
and their death. He argues that many prior studies make the assumption that the 
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symptoms reported by athletes and their families are a direct result of the brain pathology 
that can be visualized after their deaths. Gaetz points out that many of the studies on CTE 
have been case studies leading to a lack of objective evidence to prove the link between 
the two. 
         Gaetz also identifies another assumption that the retired NFL players who have 
been studied represent the general population except for the one difference of having 
suffered one or more concussive injuries.  He explains that this group of people are 
actually a “unique sub-population” as they have often endured severe physical trauma 
during their careers that can lead to long-term physical problems. In order for these 
athletes to achieve high levels of success they often must make sacrifices in parts of their 
personal lives which may lead to social isolation when they retire. This social isolation 
can also lead to issues in development of personality and identity as their primary focus 
has been on achieving success in sports.  A third distinct feature of these players is the 
ability to rise in the social hierarchy of the NFL as well as in society in general while 
playing the sport that often does not last once they retire. For these reasons, as well as the 
lack of scientific evidence showing that all CTE symptomology is a direct result of CTE 
pathophysiology, there is a clear need for a better approach to studying CTE 
symptomology in current players in the NFL as well as those who have retired. 
 Gaetz also cites a discrepancy in reports of the prevalence estimates of CTE. 
While the incidence of CTE is unknown, prevalence has been estimated as being 
anywhere from 3.7%24 to occurring up to 90%23,25. This discrepancy in prevalence has 
led to some reports stating that CTE is more prevalent than once thought and other 
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reports stating that CTE rates are being overestimated leading to confusion in those who 
are reading these papers. 
Also, there is a lack of agreement on the ability to diagnosis CTE. Most 
researchers agree that a definitive diagnosis of CTE can only made after a complete 
neuropathological assessment has been completed at autopsy, while others claim a 
diagnosis can be made based on a history of multiple concussive or sub-concussive 
events along with a positive neurological exam. This difference in methodology may lead 
to diagnoses of CTE that are not valid.  
 Some limitations of CTE research have been noted to be the methods of obtaining 
brain specimens for analysis as well as the methods of obtaining data on NFL players’ 
lives. Specimens are often donated from family members who have concerns regarding 
the behavior of a loved one before they passed making them specimens of convenience. 
Though this issue has been recognized by many researchers, studies continue to use this 
method of obtaining samples. There is also an issue of recall bias in many studies and it is 
especially important for retrospective studies to account for this. For example, some 
studies have relied on family members or friends of those who have passed away for data 
regarding their lives. Additionally, as discussed above, there is criticism of the differing 
methodology between research groups, which along with small sample sizes, difficulty in 
accounting for bias, and difficulty in obtaining accurate control groups leaves major room 
for improvement in the completion of these studies. It is also important to note that other 
studies have shown that increased neurotrauma does not always lead to a higher 
incidence neurodegenerative changes.7 Savica et al. showed that American football 
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players who played at a time with less head protection were not at an increased risk of 
developing neurodegenerative diseases, such as PD, ALS, or dementia, when compared 
to a control group of people who did not play the sport.26 Another report regarding 
Canadian Football League (CFL) players who had suffered multiple neurotraumatic 
events and who had evidence of signs and symptoms of neurodegenerative disease 
revealed that half of those studied did not have CTE neuropathology on autopsy.27  
         There is a need for as much information regarding CTE in NFL players as 
possible. A retrospective study attempted to analyze the neurodegenerative causes of 
death in NFL players to identify if there is an increased risk in neurodegenerative causes 
of death in those who play football professionally when compared to the general United 
States population. After the 1994 NIOSH mortality study of players in the NFL revealed 
an increase in “nervous system” deaths in NFL players and many retired players began to 
notice signs of cognitive decline, there became a need for more information regarding the 
effects of neurotrauma. The cohort of the Lehman et. al study consisted of 3,439 players 
who had passed away up until the year 2007.5 This paper specifically looked into 
instances of AD, PD, and ALS as causes of death for those who had played at least five 
seasons in the NFL. None of those deaths had been directly attributed to CTE; its 
neuropathology had not been determined until more recently and CTE is not a listed 
cause of death according to the International Classification of Diseases (ICD). CTE has 
been noted as a potential cause of death in cases where it was previously believed that a 
person’s cause of death was PD, AD, or ALS, though.7,24 Thus, these listed causes of 
death can serve as a proxy of CTE. They also accounted for possible misclassification by 
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reporting results for all neurodegenerative causes of death combined. This analysis 
utilized a small sample size of neurodegenerative deaths resulting in broad confidence 
intervals. Investigators were limited by using players who played at least five seasons 
professionally. The data they obtained cannot be applied to players with less than five 
seasons of playing time or those who did not play football professionally. The small 
sample size also led to an inability to group players into more than two categories based 
on their position. The players could only be grouped into speed and non-speed positions, 
though investigators hoped to perform analyses based on actual position played. 
Therefore, there is a lack of important data regarding neurodegenerative mortality risk 
based on a player’s position on the field. They also did not have data on number of 
concussions or other injuries each player may have had which would have been a 
beneficial data point to explore.  
         Though there are issues with the original study completed by Lehman and his 
team, it was still able to generate valuable information concerning the possible risk of 
neurodegenerative changes in those who play in the NFL for multiple seasons. There still 
remains a lack in the data from 2007 until 2017 that could likely aid in the discussion of 
the impact of recurrent concussive or sub-concussive events on the development of 
chronic traumatic encephalopathy. Also, a second study completed by Lehman and his 
team followed the same methods to analyze cause of death due to suicide or parasuicide.8 
Therefore, this thesis proposes a continuation of the studies originally performed by 
Lehman et. al to provide more data on the prevalence of neurodegenerative diseases in 
NFL players as well as suicide mortality.  
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METHODS 
Study design 
The proposed study will be a continuation of the original study completed by Lehman et. 
al. and will replicate their project design. It will be a retrospective cohort study that will 
be comprised of National Football League players who have passed away between 2007 
until 2017. These players will have played professionally for at least five seasons and be 
stratified into two different groups based on position: speed positions and non-speed 
positions. Internal comparisons will be made between the two groups of NFL players by 
using standardized rate ratios (SRRs). External comparisons will be made between the 
NFL players and the general United States population by using standardized mortality 
ratios (SMRs). 
Study population and sampling 
The population of this study will include every NFL player who had played at least five 
seasons professionally and who has passed away from the year 2007 until the year 2017. 
The cohort will be divided into two different groups based on position as it has been 
found that speed positions experience concussions more commonly than non-speed 
positions.28,29 Speed positions consist of quarterbacks, halfbacks, fullbacks, running 
backs, defensive backs, wide receivers, safeties, tight ends, and linebackers. The “non-
speed” position group consists of all offensive and defensive linemen. Punters and 
kickers will be excluded from this analysis. 
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Study variables 
International Classification of Diseases (ICD) codes will be utilized to identify a 
player’s cause of death and these will be based on what revision was current at the 
player’s time of death. Evaluation of neurodegenerative causes of death will be the 
specific aim of this study including AD, ALS, PD, as well as intentional self-
harm/suicide. 
Speed versus non-speed position will also be analyzed. It is important to 
determine if position on the field is a contributing factor to developing neurodegenerative 
diseases.  
Recruitment/Data Collection 
Recruitment of this cohort will be based on information from multiple sources. To ensure 
players have had at least five seasons of play, investigators will acquire information from 
the National Football League pension fund database. Vital status will also be acquired 
from the NFL pension fund database. Vital status will be confirmed by accessing records 
from the Social Security Administration and the Internal Revenue Service. Every person 
who had played for at least five seasons in the NFL and who had passed away from the 
year 2007 until the year 2017 will be included in this study. 
 Once a cohort is obtained, the National Death Index (NDI) will be utilized to 
match players with their causes of death including both underlying and contributing 
causes. The causes of death of each player will be coded by the ICD revision that was in 
place at the time of their death. Investigators will acquire death certificates of each player 
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from the vital statistics office in the state in which they perished in the event that death 
information was not available via the NDI.  
Data Analysis 
The analysis of our data will follow the investigation completed by Lehman and his team. 
The analysis of mortality will be completed using the NIOSH life table analysis system 
(LTAS.NET).  LTAS.NET is a software tool researchers can use to help analyze data. It 
analyses cohorts, in this case NFL players, over time to assess if there is an increased 
incidence in a specific disease or in mortality in a cohort when compared to a general 
population. It can also be used to complete internal comparisons for those believed to be 
at either an increased or decreased risk of exposure. The LTAS.NET system will allow 
for SMRs to be completed when comparing our cohort NFL players to the general 
population and SRRs when comparing speed and non-speed players within the cohort. 
This study will utilize United States male mortality rates from 2007 until 2017 for 119 
categories for cause of death. The evaluation of mortality as a result of neurodegenerative 
causes, including AD, ALS, and PD, will be completed by using updated custom rate 
files. Mortality as a result of suicide or self-harm will also be evaluated.  
Risk begin dates will be approximated as being the end of the fifth credited season 
of play. Investigators will use the same date (February 1st) used in the prior study. Each 
player within the study will have a person-years at risk (PYAR) calculated for each year 
of life occurring between their risk begin date and whichever date comes first between 
their date of death or the end date of the investigation. 
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         The expected number of deaths will be calculated by grouping PYAR into five-
year intervals by calendar time and age. These intervals will then be multiplied by the 
suitably matched United States race, age, and cause-specific mortality rates. The ratio of 
observed and expected number of deaths will be referred to as the SMR. Investigators 
will acquire 95% confidence intervals (CI) of the data that will be, as stated above,  
adjusted for age, race, and calendar year by five-year categories. Data with a 95% CI 
excluding unity will be considered statistically significant. PD and AD tend to be listed as 
contributing causes of death as opposed to underlying causes of death and for this reason 
further analyses will be completed using multiple cause of death (MCOD) rate files. This 
will allow for better inspection of all listed causes of death on players’ death certificates. 
 It has been proposed that players in certain positions may be at a higher risk of 
concussion due to the nature of gameplay. Lehman et. al found that players in speed 
positions had an increased risk of neurodegenerative cause of death (specifically for 
AD/PD/ALS combined, AD, and ALS but not PD). For this reason, investigators will 
examine whether or not there are mortality differences in players who have passed away 
from 2007-2017 based on the positions they had played. To accomplish this, players will 
be placed into two different groups: speed positions and non-speed positions.  The 
information regarding how to assemble these groups will found in commercial 
publications. Again, LTAS.NET will be utilized to calculate SRRs and a 95% CI for 
neurodegenerative causes and suicide will utilize the non-speed group of players to act as 
an internal comparison. 
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Timeline and resources 
The overall timeline for this study will be twenty-four months. The first phase of this 
investigation will include time that will allow for the necessary information to be 
obtained from different sources. As information needs to be obtained from multiple 
different organizations at both the state and federal levels, eighteen months will be 
allotted for this phase. 
         The second phase includes the investigation of the data and statistical analysis. 
This phase will be allotted three months. The final phase includes evaluation of the 
statistical data and the time needed to produce a written report of the study. Three months 
will be allotted for this phase.  
The necessary personnel needed for implementation of this proposed study 
includes a primary investigator, a secondary investigator, and a statistician. 
Institutional Review Board 
This proposed study with be submitted for educational exemption by the Institutional 
Review Board of the Boston University Medical Campus under 45 CFR 46.101b. If the 
proposed study is denied exemption, investigators will submit a full Institutional Review 
Board protocol for review.  
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CONCLUSION 
Discussion 
Limitations of the proposed study include that we will be obtaining data from death 
certificates. It has been shown that there is varying accuracy in the completion of death 
certificates.30,31 This may lead to the inability of our study to account for those who may 
have died from neurodegenerative causes but whose causes of death were not listed as 
such. We will be utilizing this method for this study as it is the data that we will be able 
to obtain. As noted above, this may affect our ability to find a true number of NFL 
players who have died from neurodegenerative causes. Also, because CTE is not a listed 
cause of death, it is impossible to directly investigate mortality resulting from CTE. For 
this reason, will we examine mortality from other neurodegenerative causes including 
AD, ALS, and PD as well as from suicide or self-harm. Also, conclusions of this 
proposed study will therefore not produce a direct prevalence of CTE. The results of our 
study will not yield a direct relationship between concussive or subconcussive events and 
mortality from neurodegenerative diseases but will instead provide support for prior 
findings that NFL players are at an increased risk of mortality from neurodegenerative 
diseases. We will be mindful of the issues regarding the use of death certificates for our 
study and the use of different neurodegenerative diseases to better account for CTE. 
         Another limitation that must be noted in our study is that we will have a lack of 
data regarding concussion history. We will be grouping players based on position but we 
will not have data regarding how many concussive or sub-concussive events they may 
have experienced. It would be ideal to study as part of this study since it is a popular 
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belief that there is a direct correlation between number of concussive or sub-concussive 
events and the development of CTE. We will not be addressing this topic as this would 
entail gathering histories from players’ friends and families, which would introduce recall 
bias and is not permitted in our timeframe.   
         Finally, as initially noted by Lehman and his team, the results of this prospective 
study may not be generalizable or applicable to players who do not have long-term 
careers or those who play non-professionally. There are a different set of risk factors 
experienced by professional football players, which would make it impossible to use the 
data that would be generated by this study to make assumptions about non-professional 
football players.  If the proposed cohort has a longer than average career length of 
seasons as it did in the initial study, it would be impossible to use data accumulated to 
make generalizations about players with shorter career lengths. 
Summary 
Chronic traumatic encephalopathy is a pathologically discrete neurodegenerative disorder 
that affects a diverse group of people.  The neuropathology of CTE has been found in 
those with epilepsy, those with head-banging behavior, those who suffer from IPV, and 
those who participate in contact sports. More recent attention has been given to players in 
the National Football League after it was shown that they have an increased risk of 
developing CTE and its symptomology due to the nature of their profession. 
         The validity of studies claiming to have found a direct correlation between TBI in 
professional football players and the development of CTE has been questioned. Many of 
these studies have a recall bias from asking either athletes or family members of athletes 
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about their concussive history years after they have retired. They also tend to use samples 
of convenience by acquiring brain specimens from those thought to have CTE 
symptomology prior to their passing. 
         What is clear, however, is that CTE is a distinct neuropathology that differs from 
the pathology of other neurodegenerative diseases. It is evident that more information 
regarding CTE and the ways in which it develops needs to be evaluated. While the 
proposed study will not be able to answer all of the lingering questions regarding CTE, it 
will extend the analysis of previous studies and produce more information regarding the 
possibility of an increased risk of NFL players to develop CTE. 
Clinical and/or public health significance 
This proposed study extend the analysis of the data regarding the rates of 
neurodegenerative causes of death in NFL players. Though it will not directly evaluate 
CTE as a cause of death, it will reveal whether or not there is increased risk of developing 
a neurodegenerative disease associated with CTE in those who play professional football. 
Should an increased risk be noted it would solidify the need for a better way to identify 
cases of CTE on autopsy. More attention given to this subject would encourage better 
evaluation of not only NFL players with symptomology but those with no pre-mortem 
signs of a neurodegenerative process. Only then can a concrete conclusion regarding CTE 
in NFL players be made.  
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